Abstract
and not in the context of a clinical trial. For instance is it as effective or cost-effective to provide therapy in a group rather than individually? Are the effects dependent on the expertise of the therapist? Should CBTp be confined to those who are treatment resistant who are often more chronic and stable patients or is it helpful to thosewhoare also in the acute stage? This symposium will try to answer these questions and inparticular investigate howCBTmethodology has been extended for use with other groups and with targets other than positive symptoms. The speakers are experts both in research and practice in the field. They will report on new findings from meta-analyses, randomised controlled trials of new therapies as well as new smaller feasibility and pilot studies. The papers will provide evidence to guide researchers and clinicians in the next stages of trial design and service improvement. In particular it will aid the process of service development from the guidance of several countries. The speakers represent the cutting edge of cognitive behaviour therapy and are all practitioners from across Europe.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
